Publications

5491 Results

Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)

Authors
R Vaidya;J Unger;L Qian;K Minichiello;RS Herbst;D Gandara;J Neal;T Leal;J Patel;K Dragnev;S Waqar;M Edelman;E Sigal;S Adam;S Malik;CD Blanke;M LeBlanc;K Kelly;M Redman
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 6543) poster #326; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Lung
Study Number(s)
LUNGMAP

The Medicaid Expansion of the Affordable Care Act and Participation of Patients with Medicaid in SWOG Cancer Clinical Trials

Authors
J Unger;H Xiao;R Vaidya;D Hershman
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 6505), abst 6505; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL), oral
Year
2022
Research Committee(s)
Cancer Care Delivery

Association between baseline body mass index and survival in men with metastatic hormone-sensitive prostate cancer: ECOG-ACRIN CHAARTED E3805

Authors
A Morgans;Y Chen;D Jarrard;M Carducci;G Liu;M Eisenberger;E Plimack;A Bryce;J Garcia;R Dreicer;N Vogelzang;J Picus;D Shevin;M Hussain;R DiPaola;D Cella;C Sweeney
Journal / Conference
Prostate May 10. doi: 10.1002/pros.24369. Online ahead of print
Year
2022
Research Committee(s)
Genitourinary
PMID
PMID35538398
Study Number(s)
CTSU/E3805

Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region

Authors
K Jordahl;A Shcherbina;A Kim;Y Su;Y Lin;J Wang;D Albanes;E Platz;C Tangen;L Hsu;A Kundaje;U Peters
Journal / Conference
Cancer Epidemiology Biomarkers & Prevention May 4;31(5):1077-1089
Year
2022
Research Committee(s)
Prevention and Epidemiology
PMID
PMID35438744
PMC
PMC9081195
Study Number(s)
S0000

Association of DNA damage response (DDR) gene alterations (alts) and response to neoadjuvant cisplatin-based chemotherapy (chemo) in muscle-invasive bladder cancer (MIBC) patients (pts) enrolled onto SWOG S1314

Authors
G Iyer;C Tangen;M Sarfaty;A Regazzi;IM Thompson;D McConkey;T Flaig;J Rosenberg
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 4522), poster 14; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Genitourinary
Study Number(s)
S1314

A Pragmatic Cluster-Randomized Trial of a Standing Physician Order Entry Intervention for Colony Stimulating Factor use among Patients at Intermediate Risk for Febrile Neutropenia (SWOG S1415CD)

Authors
DL Hershman;A Bansal;S Sullivan;G Lyman;W Barlow;K Arnold;K Watabayashi;A Bell-Brown;N Le-Lindqwister;C Dul;U Brown-Glaberman;R Behrens;V Vogel;N Alluri;SD Ramsey
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 1518), poster 112; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1415CD

A pragmatic cluster-randomized trial of a computerized clinical decision support system to improve colony stimulating factor prescribing for cancer patients receiving myelosuppressive chemotherapy (SWOG S1415CD)

Authors
S Ramsey;A Bansal;S Sullivan;G Lyman;W Barlow;K Arnold;K Watabayashi;A Bell-Brown;N Le-Lindqwister;C Dul;U Brown-Glaberman;R Behrens;V Vogel;N Alluri;D Hershman
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 1525), poster 119; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1415CD

Cell-free DNA methylation as a predictive biomarker of response to neoadjuvant chemotherapy for patients with muscle invasive bladder cancer in SWOG S1314

Authors
Y-T Lu;M Plets;G Morrison;A Cunha;S Cen;S Rhie;K Siegmund;S Daneshmand;D Quinn;S Lerner;D Petrylak;D McConkey;T Flaig;I Thompson;A Goldkorn
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 4506), abst 4506; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL), oral
Year
2022
Research Committee(s)
Genitourinary
Study Number(s)
S1314

A Phase III Randomized Trial of Eribulin (E) with or without Gemcitabine vs Standard of Care (SOC) for Metastatic Urothelial Carcinoma (UC) Refractory to or Ineligible for PD/PDL1 Antibody (Ab): SWOG S1937 (ClinicalTrials.gov NCT04579224)

Authors
S Sadeghi;M Plets;P Lara;C Tangen;R Bangs;S Lerner;T Flaig;D Petrylak;IM Thompson
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr TPS4608), poster 94a; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Genitourinary
Study Number(s)
S1937

Impact of Social Media on the Wellness of Pediatric and Adult Oncologists: A SWOG and COG survey

Authors
S Moerdler;M Barry;E Henry;T Lucas;A Marshall;D Dizon
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 11013), poster 204; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022